Elliott Builds Stake in Life-Science Firm Bio-Rad, WSJ Says

Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories to boost the firm’s underperforming stock price, the Wall Street Journal reported, citing people familiar with the matter.

The exact size of Elliott’s stake in Bio-Rad, a supplier of life-science tools, was unclear, the Journal said. Bio-Rad has a market value of about $6.7 billion. The firm’s stock has dropped more than 70% since a peak in late 2021.

Elliott is also a large investor in Sartorius, a German firm that Bio-Rad backs, the people said. Sartorius serves makers of biologic drugs. Bio-Rad’s stake in Sartorius is ...